This compound is a pharmaceutical intermediate designed for use in PEGylation processes. It features a Fmoc-protected amino group linked to a long polyethylene glycol chain terminated with a propanoic acid group, giving it high polarity and a flexible structure.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 756526-02-0
5,8,11,14,17,20-Hexaoxa-2-azatricosanedioic acid 1-(9H-fluoren-9-ylmethyl) ester
research compound
5,8,11,14-Tetraoxa-2-azaheptadecanedioic acid 1-(9H-fluoren-9-ylmethyl) ester
research compound
Fmoc-beta-Alanine
pharmaceutical intermediate
Tert-Butyl {2-[2-(2-bromoethoxy)ethoxy]ethyl}carbamate
pharmaceutical intermediate
3-Cyano-4,6-diaminopyridine
pharmaceutical intermediate
3-Aminoisonicotinic acid
pharmaceutical intermediate
3-Fluoro-5-iodopyridine
pharmaceutical intermediate
2-Bromo-3-chloro-5-(trifluoromethyl)pyridine
pharmaceutical intermediate
3-[2-[2-[2-[2-[2-[2-[2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid
VYXGUCLTEWCVRY-UHFFFAOYSA-N
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O